Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice
This study suggested that ADAMTS13 protein and other VWF-targeting agents may be a novel therapeutic option for treatment of pulmonary inflammatory diseases.PMID:37759076 | DOI:10.1007/s12185-023-03668-x
Source: International Journal of Hematology - Category: Hematology Authors: Yu Onodera Seiji Mitani Chihiro Hosoda Yoko Takabayashi Asuka Sakata Ryohei Kawasaki Ryota Mori Chiaki Ohshima Kenji Nishio Mitsuhiko Sugimoto Kenji Soejima Nigel Mackman Midori Shima Kohei Tatsumi Source Type: research